Form 8-K - Current report:
SEC Accession No. 0000950170-21-002562
Filing Date
2021-11-01
Accepted
2021-11-01 16:05:56
Documents
16
Period of Report
2021-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cmpx-20211101.htm   iXBRL 8-K 54670
2 EX-99.1 cmpx-ex99_1.htm EX-99.1 25997
3 EX-99.2 cmpx-ex99_2.htm EX-99.2 14632
4 GRAPHIC img174977587_0.jpg GRAPHIC 4234
5 GRAPHIC img175901108_0.jpg GRAPHIC 4234
  Complete submission text file 0000950170-21-002562.txt   239334

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmpx-20211101.xsd EX-101.SCH 2520
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmpx-20211101_lab.xml EX-101.LAB 13896
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmpx-20211101_pre.xml EX-101.PRE 10252
9 EXTRACTED XBRL INSTANCE DOCUMENT cmpx-20211101_htm.xml XML 4882
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 211367162
SIC: 2836 Biological Products, (No Diagnostic Substances)